|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| C07K 16/46 | |||
| C12N 15/85 |
| (11) | Patento numeris | 2951207 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14706169.1 |
| Europos patento paraiškos padavimo data | 2014-01-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-12-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-08-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/014175 |
| Data | 2014-01-31 |
| (87) | Numeris | WO 2014/121087 |
| Data | 2014-08-07 |
| (30) | Numeris | Data | Šalis |
| 201361759578 P | 2013-02-01 | US |
| (72) |
DAVIS, Samuel, US
SMITH, Eric, US
PATEL,Supriya, US
RAFIQUE, Ashique, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | ANTIBODIES COMPRISING CHIMERIC CONSTANT DOMAINS |
| ANTIBODIES COMPRISING CHIMERIC CONSTANT DOMAINS |